KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Shares Outstanding (2017 - 2025)

Bionano Genomics' Shares Outstanding history spans 4 years, with the latest figure at $296.9 million for Q3 2022.

  • For Q3 2022, Shares Outstanding rose 5.49% year-over-year to $296.9 million; the TTM value through Sep 2022 reached $296.9 million, up 5.49%, while the annual FY2021 figure was $289.6 million, 52.46% up from the prior year.
  • Shares Outstanding for Q3 2022 was $296.9 million at Bionano Genomics, up from $290.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $296.9 million in Q3 2022 and bottomed at $10.8 million in Q1 2019.
  • The 4-year median for Shares Outstanding is $190.0 million (2020), against an average of $169.4 million.
  • The largest annual shift saw Shares Outstanding soared 1261.24% in 2020 before it increased 3.91% in 2022.
  • A 4-year view of Shares Outstanding shows it stood at $34.3 million in 2019, then surged by 454.22% to $190.0 million in 2020, then soared by 52.46% to $289.6 million in 2021, then rose by 2.52% to $296.9 million in 2022.
  • Per Business Quant, the three most recent readings for BNGO's Shares Outstanding are $296.9 million (Q3 2022), $290.1 million (Q2 2022), and $289.7 million (Q1 2022).